SF
DXCM icon

Summit Financial’s DexCom DXCM Stock Holding History

Summit Financial’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$306K Buy
4,538
+462
+11% +$30.8K ﹤0.01% 1324
2026
Q1 		$256K Buy
4,076
+72
+2% +$5.01K ﹤0.01% 1257
2025
Q4 		$266K Sell
4,004
-70
-2% -$4.53K ﹤0.01% 1125
2025
Q3 		$274K Sell
4,074
-353
-8% -$27.9K ﹤0.01% 1089
2025
Q2 		$386K Buy
4,427
+23
+0.5% +$1.8K 0.01% 626
2025
Q1 		$301K Buy
+4,404
New +$359K 0.01% 608

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Summit Financial's DXCM Position: Q2 2026 in Review

Summit Financial increased its DexCom (DXCM) stake by 11% in Q2 2026, buying an estimated $30.8K and bringing the position to 4,538 shares worth $306K. The position accounts for ﹤0.01% of the portfolio, ranked #1324.

Summit Financial first reported a position in DXCM in Q1 2025 and has held it in 6 quarters since. The position peaked at $386K in Q2 2025. 974 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Summit Financial held 4,538 shares of DexCom worth $306K as of Q2 2026.
  • Summit Financial bought 462 DexCom shares in Q2 2026, an estimated $30.8K.
  • DexCom made up ﹤0.01% of Summit Financial's portfolio in Q2 2026, its #1324 holding.
  • Summit Financial first reported a position in DexCom in Q1 2025 and has held it in 6 quarters since.
  • Summit Financial's DexCom position peaked at $386K in Q2 2025.
  • 974 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Summit Financial's 13F filing for Q2 2026, filed 12 Aug 2026.